RE: Bounce is on9 Jan 2023 12:08
Yes, interactive investor.
The poorly worded RNS looks to have been drafted by design to slam the SP down. Are management looking at a cheap buyout? 80p?
FDA approval, the only one of its kind, 32m in the bank, no debt. Big order wins in the 5 days of January 2023 butnegative outlook for the year is a contradictory statement.
DYOR